International immunopharmacologyAnimalsSepsisCardiomyopathiesMiceLipopolysaccharides
Protective effect of Adropin on sepsis-induced cardiomyopathy.
Ji Wu, Zu-Xiang Wu, Huan Hu, Zhi-Qiang Chen, Ying-Xing Wu, Yang Fu, Fu-Lin Song, Ping Li
Published: 202610.1016/j.intimp.2025.116030
Abstract
BACKGROUND AND AIM: Sepsis-induced cardiomyopathy (SIMD) is linked to higher mortality rates in patients with sepsis, yet there are currently no targeted therapies available for this condition. Adropin, known for its anti-inflammatory, antioxidant, a…
Preview only. Read the full abstract at the source